Knowledge of HIV and hepatitis B and C status among people living in extreme poverty in France, in 2012

Chappuis, Marielle; Pauti, M.-D.; Tomasino, Anne; Fahet, G.; Cayla, Françoise; Corty, J.-F.

doi:10.1016/j.medmal.2015.01.008

Cited by 9 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several barriers to HCV treatment in PWID were previously identified in a systematic review performed in 12 European countries . Barriers at the patient level included unwillingness to be treated, lack of knowledge, low priority given to HCV, lack of financial resources and fear of side effects. Depression was also considered to potentially strengthen perceived barriers .…”

Section: Discussionmentioning

confidence: 99%

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

et al. 2019

View full text Add to dashboard Cite

Background and Aims Although people who inject drugs (PWID) are the core at‐risk population in the hepatitis C virus (HCV) epidemic in industrialized countries, few initiate treatment. Alcohol use disorder (AUD), common within this population, has been identified as a barrier to HCV treatment uptake in the general population. We investigated whether the arrival of new and well‐tolerated HCV treatments (direct‐acting antivirals: DAA) has improved HCV treatment uptake in French PWID compared with former treatments (pegylated interferon‐based treatments: Peg‐IFN). Design Using discrete‐time Cox proportional hazards models based on exhaustive care delivery data, we tested for associations between AUD (defined by AUD‐related long‐term illness status, diagnosis coding during hospitalization and/or AUD pharmacological treatment) and first HCV treatment delivery, after adjusting for gender, age, complementary universal health cover, liver disease severity and type of opioid agonist therapy (OAT) received. Separate analyses were performed for 2012–13 (Peg‐IFN era) and 2014–16 (DAA era). Setting France. Participants All French people chronically HCV‐infected who received OAT at least once during 2012–16 and were covered by the national health insurance (n = 24 831). Measurements Incidence rate of HCV treatment uptake, hazard ratios associated with AUD and other covariates. Findings Incidence rate (IR) of HCV treatment uptake per 100 person‐years was 6.56, confidence interval (CI) = 6.30–6.84; and IR = 5.70, 95% CI = 5.51–5.89 for Peg‐IFN‐based treatment (2012–13) and DAA (2014–16), respectively. After multiple adjustment, people with AUD not receiving related medication had 30 and 14% lower Peg‐IFN‐based treatment and DAA uptake, respectively, than those without AUD [hazard ratio (HR) = 0.70, 95% CI = 0.62–0.80 and HR = 0.86, 95% CI = 0.78–0.94]. No difference was observed between those treated for AUD and those without AUD. Conclusions Despite the benefits of direct‐acting antiviral treatment, untreated alcohol use disorder appears to remain a major barrier to hepatitis C virus treatment access for people who inject drugs in France.

show abstract

Section: Discussionmentioning

confidence: 99%

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

et al. 2019

View full text Add to dashboard Cite

show abstract

“…In particular, many of the MdM interventions target women’s and children’s health as well as infectious disease prevention. For instance, MdM centers in France provided free-of-charge HIV and hepatitis B and C screening for people living in extreme poverty, over 92 % of which were migrants [ 43 , 44 ]. Similarly, in Greece, the organization operates four free-of-charge clinics around the country, as well as harm reduction programs for drug users in Athens [ 106 ].…”

Section: Resultsmentioning

confidence: 99%

“…Reflecting the dearth of empirical research on the topic, our academic literature searches yielded few relevant results: six articles on the EC [ 33 – 38 ], one on the WHO [ 39 ], three on the IOM [ 40 – 42 ], two on MdM [ 43 , 44 ], two on MSF [ 45 , 46 ], and none on the OSF. Our criterion for relevance was reference to international organizations’ interventions related to migrant health in Europe.…”

Section: Methodsmentioning

confidence: 99%

International organizations and migrant health in Europe

Kentikelenis

Shriwise

2016

Public Health Rev

View full text Add to dashboard Cite

International organizations have defined and managed different aspects of migrant health issues for decades, yet we lack a systematic understanding of how they reach decisions and what they do on the ground. The present article seeks to clarify the state of knowledge on the relationship between international organizations and migrant health in Europe. To do so, we review the operations of six organizations widely recognized as key actors in the field of migrant health: the European Commission, the Regional Office for Europe of the World Health Organization, the International Organization on Migration, Médecins du Monde, Médecins Sans Frontières, and the Open Society Foundation. We find that international organizations operate in a complementary fashion, with each taking on a unique role in migrant health provision. States often rely on international organizations as policy advisors or sub-contractors for interventions, especially in the case of emergencies. These linkages yield a complex web of relationships, which can vary depending on the country under consideration or the health policy issue in question.

show abstract

“…These infections are usually accompanied by poor outcomes because people are unable to access appropriate care (e.g., low resources, no money for treatment, etc.) 3 . Unfortunately, work place environments are also associated with hepatitis B and C infections 4 .…”

Section: Dear Editormentioning

confidence: 99%

“…Department of Community Health, National University, San Diego, CA, USA. [3]. Diretoria de Pesquisa e Desenvolvimento, Fundação Ezequiel Dias, Belo Horizonte, MG, Brasil.…”

unclassified

Are waste pickers at risk for hepatitis B and C infections because of poverty or environmental exposures?

Scarponi

Zolnikov

Mol

2019

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

Knowledge of HIV and hepatitis B and C status among people living in extreme poverty in France, in 2012

Cited by 9 publications

References 13 publications

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS‐FANTASIO study)

International organizations and migrant health in Europe

Are waste pickers at risk for hepatitis B and C infections because of poverty or environmental exposures?

Contact Info

Product

Resources

About